Table 1.

Inclusion/exclusion criteria for patient enrolment

Inclusion criteria	Exclusion criteria
Between three months and thirty‐six months and soon. On ART with LPV/r syrup or soon to be initiated on an LPV/r‐based regimen. Caregiver/infant had not missed more than one follow‐up appointment in accordance with their visit schedule. A primary caregiver provided written consent for his/her child to enrol in the pilot study	Had an active opportunistic infection or co‐morbidities, or otherwise showed clinical symptoms of severe or advanced HIV disease as defined by the WHO clinical staging. Were already on LPV/r tablet formulation without any problems. Were prescribed on medication with a drug–drug interaction with LPV/r

ART, antiretroviral therapy; LPV/r, lopinavir/ritonavir; WHO, World Health Organization.